Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations

Archives of Cardiovascular Diseases

Volumn 101, Issue 7-8, 2008, Pages 491-500

  Monassier, Jean Pierre ^a  

^a Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

Acute myocardial infarction; Reperfusion injury; Reperfusion injury salvage kinase pathway

Indexed keywords

CARDIOVASCULAR AGENT; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ACUTE HEART INFARCTION; APOPTOSIS; CARDIOVASCULAR INFLAMMATION; CELL DAMAGE; CELL SURVIVAL; CELL SWELLING; CELL VIABILITY; CORONARY ARTERY BLOOD FLOW; CYTOSKELETON; DISEASE COURSE; DNA DAMAGE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART CATHETERIZATION; HEART CONTRACTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REOXYGENATION; REPERFUSION INJURY; REVIEW; SALVAGE THERAPY; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION; VASCULAR ENDOTHELIUM;

EID: 56049125762     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.06.014     Document Type: Review

References (60)

1. Van de Werf F, Ardissimo D, Betriu A, et al. Management of acute myacardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
2. Boersma E, The Primary Angioplasty vs Thrombolysis (PCAT)-2 Trialists Collaborative Group. Does time matter? A Pooled analysis of randomize clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-88.
3. Monassier JP, Gressin V, Louvard Y, et al. Myocardial reperfusion syndrome. Arch Mal Coeur Vaiss 1992;85:743-50.
4. Komamura K, Kitazake M, Nishida K, et al. Progressive decrease in coronary vein flow during reperfusion in acute myocardial infarction: documentation of the no-reflow phenomenon after successful thrombolysis. J Am Coll Cardiol 1994;24:370-7.
5. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocarial necrosis induced by temporary occlusion of a coronary artery in dogs. Arch Path 1960;70:68-78.
6. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985;76:1713-9.
7. Nayler WG, Elz JS. Reperfusion injury: laboratory arterfact or clinical dilemma? Circulation 1986;74:215-21.
8. Forman MB, Perry JM, Wilson H, et al. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991;18:911-8.
9. Wang QD, Pernow J, Sjöquist PO, Ryden L. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 2002;55:25-37.
10. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-88.
11. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal injury in ischemic myocardium. Circulation 1986;74:1124-36.
12. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005;112:2143-8.
13. Garcia-Dorado D, Piper HM. Postconditioning: reperfusion of 'reperfusion injury' after hibernation. Cardiovasc Res 2006;69:1-3.
14. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
15. Opie LH. Myocardial infarct size. Part I. Basic Condiderations. Am Heart J 1980;100:355-72.
16. Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circulation 1987;60:153-68.
17. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave front phenomenon of ischemic cell death. Circulation 1997;56:786-93.
18. James TJ. The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis. Coron Artery Dis 1998;9:291-307.
19. + exchange immediately during reperfusion. Am J Physiol 1997;273:H2232-9.
20. Imahashi K, Kusuoka H, Hashimoto K, Yoshioka J, Yamaguchi H, Nishimura T. Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 1999;84:1401-6.
21. Murphy E, Cross H, Steebergen C. Sodium regulation during ischemia versus reperfusion and its role in injury. Circ Res 1999;84:1469-70.
22. Piper HM, Kasseckert S, Abdallah Y. The sarcoplasmic reticulum as the primary target of reperfusion protection. Cardiovasc Res 2006;70:170-3.
23. Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978;73:843-9.
24. Matsumara K, Jeremy RW, Schaper J, Becker LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1998;97:795-804.
25. Burton KP, McCord JM, Ghai G. Myocardial alteration due to free-radical generation. Am J Physiol 1984;246:H776-83.
26. McCord JM. Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med 1985;312:158-63.
27. Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-90.
28. Hearse DJ, Humphrey SM, Bullock GR. The oxygen paradox: two facets of the same problem? J Mol Cell Cardiol 1978;10:641-68.
29. Zimmet JM, Hare JM. Nitroso-redox interactions in the cardiovascular system. Circulation 2006;114:1531-44.
30. Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that 'myocardial stunning' is a manifestation of reperfusion injury. Circ Res 1989;65:607-22.
31. Garcia-Dorado D, Théroux P, Duran JM, et al. Selective inhibition of the contractile apparatus: a new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992;85:1160-74.
32. Piper HM, Garcia-Dorado D. Prime causes of rapid cardiomyocyte death during reperfusion. Ann Thorac Surg 1999;68:1913-9.
33. Gateau-Roesch O, Argaud L, Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006;70:264-73.
34. +. Am J Physiol 1990; 258:H1025-31.
35. Di Lisa F, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: Fixing a hole. Cardiovasc Res 2006;70:199-209.
36. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning. Staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007;115: 1895-903.
37. 2+ overloading, trigger Ph and mitochondrial permeability transition - dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol 2006;290:H2024-34.
38. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-35.
39. Go LO, Murry CE, Richard VJ, Weischedel GR, Jennings RB, Reimer KA. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible injury. Am J Physiol 1988;255:H1188-98.
40. Smith EF, Egan JW, Bugelski PJ, Hillegass LM, Griswold DE. Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am J Physiol 1988;20:H1060-8.
41. Baxter GF. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 2002;97:268-75.
42. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004;61:481-97.
43. O'Neill PG, Charlat ML, Michael LH, Roberts R, Bolli R. Influence of neutrophil depletion on myocardial function and flow after reversible ischemia. Am J Physiol 1989;256:H341-51.
44. Hanssen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
45. Stahl G, Xu Y, Hao L, et al. Role for the alternative complement parhway in ischemia/reperfusion injury. Am J Pathol 2003;162:449-55.
46. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol 2001; 280:H2649-57.
47. Vinten-Johansen J, Yellon DM, Opie H. Postconditioning. A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005;112:2085-8.
48. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004;44:1103-10.
49. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM, Postconditioning:. A form of 'modified reperfusion' protects the myocardium by activating the phosphatidylinositol 3-Kinase-Akt pathway. Circ Res 2004;95:230-2.
50. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK) pathway. Cardiovasc Res 2004;61:448-60.
51. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol 2005;289:H2-7.
52. + channels and myocardial preconditioning. Circ Res 1999; 84:973-9.
53. 2+ overload during simulated ischemia and reperfusion. Possible mechanism of cardioprotection. Circ Res 2001;89:891-8.
54. Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3B mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004;113:1535-49.
55. Bopassa JC, Michel P, Gateau-Roesch O, Ovize M, Ferrara R. Low-pressure reperfusion alters mitochondrial permeability transition. Am J Physiol 2005;288:H2750-5.
56. Ramzy D, Rao V, Weisel R. Clinical applicability of preconditioning and preconditioning: the cardiothoracic surgeons's view. Cardiovasc Res 2006;70:174-80.
57. Gunaydin B, Cakici I, Soncul H, et al. Does remote organ ischemia trigger preconditioning during coronary artery surgery? Pharmacol Res 2000;41:493-6.
58. Wolfrum S, Schneider K, Heidbreder M, Nienstedt J, Dominiak P, Dendorfer A. Remote preconditioning protects the heart by activating myocardial PKCepsilon isoform. Cardiovasc Res 2002;55:583-9.
59. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart 2000;83:381-7.
60. Fliss H. Accelerated apoptosis in reperfused myocardium: friend or foe? Basic Res Cardiol 1998;93:90-3.